Business Wire

The Estée Lauder Companies and BALMAIN are Partnering to Launch BALMAIN BEAUTY

Share

The Estée Lauder Companies Inc. (NYSE: EL) (“ELC”) and BALMAIN have entered into a license agreement to collaboratively develop, produce, and distribute an innovative line of beauty products that will speak to luxury consumers around the world: BALMAIN BEAUTY. The collaboration is expected to launch in fall 2024, with the goal to transform the luxury and couture beauty world through exceptional design, singular craftsmanship, and an unyielding commitment to innovation.

In 1945, when founder Pierre Balmain boldly introduced his audacious, fresh, and feminine “New French Style,” Balmain helped post-war Paris begin to regain its title as the fashion world’s capital. Today’s BALMAIN, under the visionary leadership of Creative Director Olivier Rousteing since 2011, builds upon Pierre Balmain’s legacy, with the house’s rich archives providing key inspirations and the legendary savoir-faire of Balmain’s atelier ensuring the success of Rousteing’s distinctive “Renewed French Style.” While revering the past, Rousteing has assumed a pioneering role in advocating for a more inclusive fashion world, while he and his team also expand design possibilities, relying on time-honored Parisian couture techniques to masterfully perfect the latest 21st-century breakthroughs.

Founded in 1946 by the remarkable female entrepreneur, Estée Lauder, today The Estée Lauder Companies is the global leader in prestige and luxury beauty, celebrating the diversity of the world and inspiring consumers to express their individual beauty. As the only company focused solely on prestige and luxury makeup, skin care, fragrance, and hair care, the company’s brands are sold in approximately 150 countries and territories. Infused throughout the family company are deep-rooted values and a rich history, as well as a passion for creativity and innovation and a desire to push boundaries and invent the unexpected. Drawing inspiration from the bold and breakthrough efforts of Estée Lauder, who helped invent the modern beauty industry, the company is at the forefront of social and environmental impact, with equity and sustainability as top priorities.

“For over ten years, my BALMAIN team and I have been pushing the boundaries of what is possible in fashion,” notes Mr. Rousteing. “We’ve been determined to reflect the way that today’s diverse generation wishes to live and dress. So, obviously, there was no way that we were going to expand into beauty without ensuring that we had found the partner who understood and shared our outlook. From the very beginning, the team at The Estée Lauder Companies made it very clear that they support BALMAIN’s distinctive vision, as well as our goal of disrupting the global luxury beauty paradigm. Knowing that — and knowing that Estée Lauder is the paragon of excellence — well, I can’t wait to start working with them.”

Guillaume Jesel will be appointed President, Global Brands, TOM FORD BEAUTY, BALMAIN BEAUTY and Luxury Business Development, effective immediately. “BALMAIN and Olivier Rousteing are visionary forces in global fashion. We look forward to working with them to expand the BALMAIN universe and forge a new space in luxury beauty that clearly reflects the strong, inclusive, and fearless spirit of the brand,” said Mr. Jesel.

Follow on Instagram @Balmainbeauty.

About The Estée Lauder Companies Inc.

The Estée Lauder Companies (“ELC”) is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD BEAUTY, Smashbox, Aerin Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.

About BALMAIN

For more than ten years, BALMAIN’s Creative Director, Olivier Rousteing, has been inventively building upon Pierre Balmain’s extraordinary legacy, while always remaining true to his own determination to design clothes that reflect the way his inclusive, powerful, and global BALMAIN customer wishes to live today. The result is a unique and instantly recognizable BALMAIN silhouette, style and attitude that highlights the singular craftsmanship of the house’s celebrated ateliers, while consistently referencing a rich Parisian heritage. For more information, please visit balmain.com.

[The forward-looking statements in this press release, including those in the quoted remarks and those relating to the expected launch and expectations for BALMAIN BEAUTY involve risks and uncertainties. Factors that could cause actual results to differ materially from those forward-looking statements include current economic and other conditions in the global marketplace, actions by retailers, suppliers and consumers, competition, the ongoing success of the collaborative relationship of the parties, the abilities to implement the plan, and those risk factors described in ELC’s annual report on Form 10-K for the year ended June 30, 2022.]

ELC-C

ELC-B

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Investor Relations:
Rainey Mancini
rmancini@estee.com

Media Relations:
Jill Marvin
jimarvin@estee.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The 4 th World Science and Technology Development Forum Held in Chengdu28.11.2022 17:06:00 CET | Press release

The 4th World Science and Technology Development Forum with the theme “Openness, Trust and Cooperation” kicked off in Chengdu on November 27, 2022, which was attended by more than 300 top experts and scholars, representatives of international organizations, and entrepreneurs, from more than 20 countries and regions, including 7 Nobel laureates and more than 60 academicians home and abroad. Together, they discussed technological innovation and sustainable development in key fields such as basic science, climate change, digital economy, and green innovation, and proposed technological innovation solutions to address the challenges of today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005539/en/ The 4th World Science and Technology Development Forum Held in Chengdu (Photo: Business Wire) The world today is facing many challenges, such as the COVID-19 pandemic, energy security, food security, climate change, poverty, an

Biocytogen Enters into Antibody Agreement with ADC Therapeutics28.11.2022 15:47:00 CET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant ADC Therapeutics a license to evaluate Biocytogen’s proprietary antibodies against three tumor targets, with an option to license selected antibodies at a later date for global ADC development and commercialization. Biocytogen reserves all global rights for these antibodies beyond ADC development. Biocytogen will receive an upfront payment. For each option exercised, Biocytogen will be entitled to an option-exercise fee, and development and commercial milestone payments, which potentially total tens of millions of US dollars, as well as single-digit royalties on net sales. Under the agreement, Biocytogen will provide ADC Therapeutics with monoclonal and/or biparatopic antibodies directed against three tumor targets, generated through Biocytogen’s Project Integrum (also called RenMiceTM HiTS

Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members28.11.2022 15:15:00 CET | Press release

Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced new appointments to its Board of Directors, effective immediately. Meinhard F. Schmidt, an international MedTech/BioTech and Digital Health executive with 25+ years of experience, has been named Board Chairman; and Anne Le Grand,an accomplished healthcare executive and consultant with 30+ years in the global healthcare technology industry, has joined as an independent board member. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005146/en/ Medimaps Group Announces Board Members: Meinhard F. Schmidt as Board Chairman, and Anne Le Grand Plus Five Other Members and One Strategic Advisor. (Photo: Business Wire) Five additional board members and one board advisor have also been named, bolstering Medimaps investment and clinical policy expertise. Visit Medimaps website fo

Viz.ai Appoints Radiology Advisory Board to Advance Innovation28.11.2022 14:00:00 CET | Press release

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support radiologists and patients. The Board consists of 14 leading healthcare experts with diverse experience and roles in radiology. “I am honored to co-chair the Radiology Advisory Board and excited about Viz.ai’s commitment to customers and patients to invest in innovation that increases access to life-saving therapies,” said Kevin Abrams, MD, medical director of neuroradiology and MRI and chief of radiology at Baptist Hospital in Miami. “I am looking forward to the rich dialogue to be discussed in our inaugural meeting, exploring future ideas.” “I’m looking forward to working with these esteemed board members to help shape Viz.ai’s Radiology Program through patient-centric vision, passion, and insights,” said Suzie Bash, MD, Co-Chair of the Viz.ai Radiology Advisory Board a

Viz.ai Launches AI-powered Viz™ Radiology Suite28.11.2022 14:00:00 CET | Press release

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the introduction of an AI-powered radiology suite, specifically designed to alert the radiologist in their workflow of suspected diseases, prioritize worklists, and connect care teams in real-time. The Viz™ Radiology Suite integrates into the picture archiving and communication systems (PACS) of healthcare organizations to securely facilitate access to imaging data across departments and streamline patient diagnosis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005172/en/ Screen shots of Viz Radiology Suite including worklist and PACS integration (Graphic: Business Wire) “With an increasing demand for imaging studies and a global shortage of radiologists, technologies that can be easily integrated into radiology workflows to enhance efficiency and streamline patient care are sorely needed,” said Allan Brook, M.D., FA

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom